Please assess the completion status of the following clinical trial:

Trial Title: Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologic proof of adenocarcinoma consistent with ductal carcinoma of pancreas or ampulla, with no evidence of metastatic disease by clinical exam or cross-sectional imaging.~* Fitness for chemotherapy in judgement of treating physician~* Bilirubin \< 4 (any means of biliary drainage acceptable)~Exclusion Criteria:~* Medical or mental illness precluding provision of informed consent~* Pregnancy~* Active infection for which neutropenia would pose high risk of mortality

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Resectable, Low Risk (Type: EXPERIMENTAL): Systemic chemotherapy followed by definitive surgery without pre-operative or post-operative radiotherapy.
- Locally Advanced (Type: EXPERIMENTAL): Systemic chemotherapy followed by chemoradiation, followed by definitive surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).